Kalmb Biiotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.60 M
- Revenue Growth -24.79%
- Profit Growth -74.85%
- Ebitda -66.75%
- Net Worth 7.12%
- Total Assets 5.63%
About Kalmb Biiotech
Kalmb Biiotech Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2014 and has a history of 11 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.60 M.
Muthukuri Balakrishna and Lakshmi Saggere serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01403TG2014PTC092157
-
Company No.
092157
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jan 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Kalmb Biiotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Saggere
|
Managing Director | 03-Jan-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Muthukuri Balakrishna
|
Whole-Time Director | 03-Jan-2014 | Current |
Financial Performance of Kalmb Biiotech.
Kalmb Biiotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 24.79% decrease. The company also saw a substantial fall in profitability, with a 74.85% decrease in profit. The company's net worth moved up by a moderate rise of 7.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalmb Biiotech?
In 2020, Kalmb Biiotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mother Agri Biotech Laboratories India Private LimitedMuthukuri Balakrishna and Lakshmi Saggere are mutual person
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2018 | Others | ₹0.60 M | Open |
How Many Employees Work at Kalmb Biiotech?
Unlock and access historical data on people associated with Kalmb Biiotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalmb Biiotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalmb Biiotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.